Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy

View previous topic View next topic Go down

Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy

Post  Jon Moulton on Mon Sep 19, 2016 4:34 pm

Hammond SM, Hazell G, Shabanpoor F, Saleh AF, Bowerman M, Sleigh JN, Meijboom KE, Zhou H, Muntoni F, Talbot K, Gait MJ, Wood MJ. Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy. Proc Natl Acad Sci U S A. 2016 Sep 12. pii: 201605731. [Epub ahead of print]

Jon Moulton

Posts : 4899
Join date : 2010-03-12
Age : 54
Location : Philomath, Oregon, USA

View user profile http://www.gene-tools.com

Back to top Go down

View previous topic View next topic Back to top

- Similar topics

 
Permissions in this forum:
You cannot reply to topics in this forum